Sign in

CIK 0001396814 · Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
510619477
Phone
650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
  1. 4 Planned sale Chief Financial Officer sold 12,060 shares at $22.09 ($266,405)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 6,690 shares (to pay taxes)
  3. 4 Planned sale Director sold 2,354 shares at $27.19 ($64,005)
  4. 4 Open-market sale Director sold 4,912 shares at $23.67 ($116,267)
  5. 4 Shares withheld for taxes Chief Medical Officer gave up 315 shares (to pay taxes)
  6. 4 Grant or award Director acquired 9,999 shares (grant or award)
  7. 4 Grant or award Director acquired 6,163 shares (grant or award)
  8. 4 Grant or award Director acquired 6,163 shares (grant or award)
  9. 4 Grant or award Director acquired 6,163 shares (grant or award)
  10. 4 Grant or award Director acquired 6,163 shares (grant or award)
  11. 4 Grant or award Director acquired 6,163 shares (grant or award)
  12. 4 Grant or award Director acquired 6,163 shares (grant or award)
  13. 4 Grant or award Director acquired 6,163 shares (grant or award)
  14. 4 Open-market sale Senior Vice President, Finance sold 5,578.34 shares at $26.21 ($146,208)
  15. 4 Open-market sale Chief Administrative Officer sold 14,376 shares at $26.24 ($377,226)
  16. 4 Shares withheld for taxes Chief Medical Officer gave up 5,084 shares (to pay taxes)
  17. 4 Grant or award Chief Medical Officer acquired 93,600 shares (grant or award)
  18. 4 Grant or award Chief Administrative Officer acquired 79,200 shares (grant or award)
  19. 4 Grant or award Chief Executive Officer acquired 350,000 shares (grant or award)
  20. 4 Grant or award Chief Commercial Officer acquired 54,000 shares (grant or award)

Page 3 of 35 · 695 filings